CARM Carisma Therapeutics Inc.: institutional ownership and insider trading
2 funds reported holding $12 of Carisma Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net sold $7.51K, with 0 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of CARM
Recent CARM insider trades
- Oct 7, 2025: Klichinsky Michael sold 56,982 shares ($14.2K)
- Oct 3, 2025: Klichinsky Michael sold 484,347 shares ($124K)